{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:21:56Z","timestamp":1793020916915,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.micpath.2022.105640","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:30:55Z","timestamp":1655260255000},"page":"105640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Relevant insights into onychomycosis\u2019 pathogenesis related to the effectiveness topical treatment"],"prefix":"10.1016","volume":"169","author":[{"given":"Polyana de Souza","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Franco","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-8872","authenticated-orcid":false,"given":"Melyssa","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-9046","authenticated-orcid":false,"given":"Terezinha Inez Estivalet","family":"Svidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.micpath.2022.105640_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/ijd.14346","article-title":"Global perspectives for the management of onychomycosis","volume":"58","author":"Gupta","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.149.s65.4.x","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"65","author":"Faergemann","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1203475417716362","article-title":"Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment","volume":"21","author":"Gupta","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"issue":"11","key":"10.1016\/j.micpath.2022.105640_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jdv.12323","article-title":"The prevalence of onychomycosis in the global population: a literature study","volume":"28","author":"Sigurgeirsson","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.micpath.2022.105640_bib5","unstructured":"Di Chiacchio N, Suarez MV, Madeira CL, Loureiro WR. An observational and descriptive study of the epidemiology of and therapeutic approach to onychomycosis in dermatology offices in Brazil. An. Bras. Dermatol.. 2013;88 Suppl 1. Accessed June 1, 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/23539065\/."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jaad.2020.05.143","article-title":"Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: a systematic review","volume":"85","author":"Stewart","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.micpath.2022.105640_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3201\/eid1910.120847","article-title":"Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2016.01.008","article-title":"The role of biofilms in onychomycosis","volume":"74","author":"Gupta","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.23736\/S0392-0488.18.06001-7","article-title":"Evidence for biofilms in onychomycosis","volume":"154","author":"Gupta","year":"2019","journal-title":"G. Ital. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.micpath.2022.105640_bib11","article-title":"The role of topical antifungal therapy for onychomycosis and the emergence of newer agents","volume":"7","author":"Del Rosso","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11592120-000000000-00000","article-title":"Health-related quality of life in patients with nail disorders","volume":"12","author":"Reich","year":"2011","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib13","article-title":"Oral antifungal medication for toenail onychomycosis","volume":"7","author":"Kreijkamp-Kaspers","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/pde.13561","article-title":"Onychomycosis in children: safety and efficacy of antifungal agents","volume":"35","author":"Gupta","year":"2018","journal-title":"Pediatr. Dermatol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib15","doi-asserted-by":"crossref","DOI":"10.5070\/D3223030383","article-title":"Antifungal agents for onychomycosis: new treatment strategies to improve safety","volume":"22","author":"Zane","year":"2016","journal-title":"Dermatol. Online J."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib16","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1097\/MJT.0000000000000696","article-title":"Antifungal drug use for onychomycosis","volume":"26","author":"Thomas","year":"2019","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09546634.2020.1729336","article-title":"Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis","volume":"33","author":"F\u00e1vero","year":"2022","journal-title":"J. Dermatol. Treat."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2022.105640_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2009.11.019","article-title":"Investigation of different formulations for drug delivery through the nail plate","volume":"386","author":"Vejnovic","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2022.105640_bib19","doi-asserted-by":"crossref","first-page":"101774","DOI":"10.1016\/j.jddst.2020.101774","article-title":"Onychomycosis: novel strategies for treatment","volume":"57","author":"Aggarwal","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/myc.12037","article-title":"Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study","volume":"56","author":"Tietz","year":"2013","journal-title":"Mycoses"},{"issue":"3\u20134","key":"10.1016\/j.micpath.2022.105640_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1473-2130.2004.00095.x","article-title":"Nail abrasion","volume":"2","author":"Di Chiacchio","year":"2003","journal-title":"J. Cosmet. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09546634.2016.1151856","article-title":"An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.)","volume":"27","author":"Shemer","year":"2016","journal-title":"J. Dermatol. Treat."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/myc.12592","article-title":"Understanding the formidable nail barrier: a review of the nail microstructure, composition and diseases","volume":"60","author":"Baswan","year":"2017","journal-title":"Mycoses"},{"issue":"44","key":"10.1016\/j.micpath.2022.105640_bib24","doi-asserted-by":"crossref","first-page":"e5141","DOI":"10.1097\/MD.0000000000005141","article-title":"The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: a randomized, controlled trial","volume":"95","author":"Zhou","year":"2016","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/14764172.2018.1502451","article-title":"Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis","volume":"21","author":"Bonhert","year":"2019","journal-title":"J. Cosmet. Laser Ther."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09546634.2011.588191","article-title":"A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial","volume":"23","author":"Bassiri-Jahromi","year":"2012","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09546634.2018.1509046","article-title":"Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis","volume":"30","author":"Abd El-Aal","year":"2019","journal-title":"J. Dermatol. Treat."},{"issue":"7","key":"10.1016\/j.micpath.2022.105640_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1346-8138.13816","article-title":"Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study","volume":"44","author":"Watanabe","year":"2017","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2336\/nishinihonhifu.82.103","article-title":"Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases : a multicenter, single-arm study","volume":"82","author":"Iozumi","year":"2020","journal-title":"Nishi Nihon Hifuka"},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7547\/14-088","article-title":"Efinaconazole topical solution, 10% efficacy in patients with onychomycosis and coexisting Tinea pedis","volume":"105","author":"Markinson","year":"2015","journal-title":"J. Am. Podiatr. Med. Assoc."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib32","author":"Number","year":"2021","journal-title":"26. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis. Skin Therapy Letter. Published"},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jaad.2020.06.1004","article-title":"Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: open-label phase 4 study","volume":"84","author":"Eichenfield","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-2133.2011.10766.x","article-title":"Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome\u00ae) in patients with onychomycosis","volume":"166","author":"Dominicus","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaad.2020.06.055","article-title":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: a randomized, multicenter, double-blind, vehicle-controlled phase 3 study","volume":"85","author":"Gupta","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/myc.13392","article-title":"A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis","volume":"65","author":"Blume-Peytavi","year":"2022","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/pde.12064","article-title":"Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy","volume":"30","author":"Friedlander","year":"2013","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13934","article-title":"Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial","volume":"173","author":"Auvinen","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib40","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1111\/j.1439-0507.2010.01898.x","article-title":"Therapeutic efficacy of topical OLEOZON\u00ae in patients suffering from onychomycosis","volume":"54","author":"Men\u00e9ndez","year":"2011","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1439-0507.2012.02215.x","article-title":"Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study","volume":"55","author":"Emtestam","year":"2012","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cpm.2021.06.005","article-title":"Biofilms and the nail unit","volume":"38","author":"Castillo","year":"2021","journal-title":"Clin. Podiatr. Med. Surg."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/pde.14214","article-title":"Dermatologic conditions in Down syndrome: a single-center retrospective chart review","volume":"37","author":"Rork","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/pde.14731","article-title":"Dermatologic conditions in Down syndrome","volume":"2","author":"Ryan","year":"2021","journal-title":"Pediatr. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaad.2018.12.070","article-title":"Skin changes in the obese patient","volume":"81","author":"Hirt","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000475674","article-title":"Hemodialysis and kidney transplantation as predisposing conditions to onychomycosis","volume":"137","author":"Filho","year":"2017","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib47","first-page":"8","article-title":"Transmission of onychomycosis and dermatophytosis between household members: a scoping review","author":"Jazdarehee","year":"2022","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40257-018-0403-4","article-title":"A practical guide to curing onychomycosis: how to maximize cure at the patient, organism, treatment, and environmental level","volume":"20","author":"Gupta","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib49","first-page":"891","article-title":"Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional - observational study","volume":"32","author":"Akkus","year":"2016","journal-title":"Pakistan J. Med. Sci. Q"},{"issue":"12","key":"10.1016\/j.micpath.2022.105640_bib50","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.12533","article-title":"Epidemiology of onychomycosis in Crete, Greece: a 12-year study","volume":"59","author":"Maraki","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2022.105640_bib51","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2147\/DDDT.S136986","article-title":"New insight into the pathogenesis of nail psoriasis and overview of treatment strategies","volume":"11","author":"Ventura","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5114\/pdia.2017.68299","article-title":"The prevalence and etiological factors of onychomycosis in psoriatic patients","volume":"35","author":"Romaszkiewicz","year":"2018","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.micpath.2022.105640_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9113418","article-title":"Overall prevalence and prevalence compared among psoriasis treatments of onychomycosis in patients with nail psoriasis and fungal involvement","author":"Chularojanamontri","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib54","first-page":"8","article-title":"Fungal infections and nail psoriasis: an update","author":"Kyriakou","year":"2022","journal-title":"J. Fungi"},{"issue":"9","key":"10.1016\/j.micpath.2022.105640_bib55","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/myc.13331","article-title":"Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment","volume":"64","author":"Grynszpan","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/myc.12542","article-title":"Onychomycosis in patients with nail psoriasis: a point to point discussion","volume":"60","author":"Rigopoulos","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2022.105640_bib57","first-page":"40","article-title":"Psoriasis with onychomycosis in a diabetic patient","author":"Natarajan","year":"2021","journal-title":"Pan Afr. Med. J."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib58","first-page":"259","article-title":"Analysis of the factors influencing the therapeutic effects of onychomycosis","volume":"21","author":"Zheng","year":"2001","journal-title":"J. Tongji Med. Univ."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000516662","article-title":"Onychomatricoma with onychomycosis: a case report and review of the literature","volume":"7","author":"Jaeger","year":"2021","journal-title":"Skin Appendage Disord."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib60","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clindermatol.2010.03.037","article-title":"Nutrition and nail disease","volume":"28","author":"Cashman","year":"2010","journal-title":"Clin. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clindermatol.2013.06.006","article-title":"Nail anatomy","volume":"31","author":"de Berker","year":"2013","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib62","series-title":"Onychomycosis","author":"Bodman","year":"2022"},{"issue":"5\u20136","key":"10.1016\/j.micpath.2022.105640_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11046-008-9105-4","article-title":"Secreted proteases from dermatophytes","volume":"166","author":"Monod","year":"2008","journal-title":"Mycopathologia"},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib64","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/jid.2013.41","article-title":"Keratin degradation by dermatophytes relies on cysteine dioxygenase and a sulfite efflux pump","volume":"133","author":"Grumbt","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s13104-016-2302-1","article-title":"Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns","volume":"9","author":"Eba","year":"2016","journal-title":"BMC Res. Notes"},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.29252\/cmm.3.4.26","article-title":"Mycological aspects of onychomycosis in Khuzestan Province, Iran: a shift from dermatophytes towards yeasts","volume":"3","author":"Fatahinia","year":"2017","journal-title":"Curr. Med. Mycol."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib67","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jcla.21973","article-title":"Causative agents of onychomycosis: a 7-year study","volume":"30","author":"Chadeganipour","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"issue":"15","key":"10.1016\/j.micpath.2022.105640_bib68","first-page":"21","article-title":"Microbial virulence factors","author":"Leit\u00e3o","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3314\/jjmm.50.253","article-title":"[Usefulness of pathological diagnosis for two cases of candidal onychomycosis]","volume":"50","author":"Kobayashi","year":"2009","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"issue":"9","key":"10.1016\/j.micpath.2022.105640_bib70","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10096-015-2410-1","article-title":"Kioshima-Cotica \u00c9S, Svidzinski TIE. Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients","volume":"34","author":"Galletti","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105640_bib71","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2217\/fmb-2018-0245","article-title":"Fusarium oxysporum is an onychomycosis etiopathogenic agent","volume":"13","author":"Veiga","year":"2018","journal-title":"Future Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apm.12835","article-title":"Exocellular extract of Fusarium oxysporum, fungus free, is able to permeate and act selectively in skin","volume":"126","author":"Sibin Melo","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.micpath.2022.105640_bib73","doi-asserted-by":"crossref","first-page":"118246","DOI":"10.1016\/j.saa.2020.118246","article-title":"Immune response and Raman scattering assessment in rats skin after contact with Fusarium oxysporum metabolites","volume":"234","author":"Correia","year":"2020","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"8","key":"10.1016\/j.micpath.2022.105640_bib74","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-4632.2007.03120.x","article-title":"Fusarium spp. as agents of onychomycosis in immunocompetent hosts","volume":"46","author":"Guilhermetti","year":"2007","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000093862","article-title":"Spores, sporodochia and fomites in onychomycosis","volume":"213","author":"Pi\u00e9rard","year":"2006","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib76","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11046-017-0222-9","article-title":"A review of onychomycosis due to Aspergillus species","volume":"183","author":"Bongomin","year":"2018","journal-title":"Mycopathologia"},{"issue":"36","key":"10.1016\/j.micpath.2022.105640_bib77","doi-asserted-by":"crossref","first-page":"22473","DOI":"10.1073\/pnas.2003700117","article-title":"Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance","volume":"117","author":"Kowalski","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2022.105640_bib78","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3389\/fmicb.2020.01980","article-title":"A two-way road: antagonistic interaction between dual-species biofilms formed by and","volume":"11","author":"Garcia","year":"2020","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib79","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10103-014-1689-y","article-title":"A new model of in vitro fungal biofilms formed on human nail fragments allows reliable testing of laser and light therapies against onychomycosis","volume":"30","author":"Vila","year":"2015","journal-title":"Laser Med. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib80","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/08927014.2014.919282","article-title":"In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms","volume":"30","author":"Costa-Orlandi","year":"2014","journal-title":"Biofouling"},{"issue":"6","key":"10.1016\/j.micpath.2022.105640_bib81","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.micron.2010.03.011","article-title":"Interaction of Candida parapsilosis isolates with human hair and nail surfaces revealed by scanning electron microscopy analysis","volume":"41","author":"Oliveira","year":"2010","journal-title":"Micron"},{"issue":"11","key":"10.1016\/j.micpath.2022.105640_bib82","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1099\/jmm.0.000175","article-title":"Miltefosine is effective against Candida albicans and Fusarium oxysporum nail biofilms in vitro","volume":"64","author":"Machado Vila","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2022.105640_bib83","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0214-2019","article-title":"Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens","volume":"53","author":"Mohammadi","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"14","key":"10.1016\/j.micpath.2022.105640_bib84","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2174\/1381612826666200217120321","article-title":"Activity of metal-azole complexes against biofilms of Candida albicans and Candida glabrata","volume":"26","author":"Pereira","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"issue":"7","key":"10.1016\/j.micpath.2022.105640_bib85","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1099\/jmm.0.000528","article-title":"Quantitative and structural analyses of the in vitro and ex vivo biofilm-forming ability of dermatophytes","volume":"66","author":"Brilhante","year":"2017","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ijd.15747","article-title":"Characterization of a biofilm formed by Fusarium oxysporum on the human nails","volume":"61","author":"Veiga","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.micpath.2022.105640_bib87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fmicb.2018.00779","article-title":"Propolis extract for onychomycosis topical treatment: from bench to clinic","volume":"9","author":"Veiga","year":"2018","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2022.105640_bib88","article-title":"Onychomycosis: current trends in diagnosis and treatment","volume":"88","author":"Westerberg","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.micpath.2022.105640_bib89","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2016.03.008","article-title":"An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates","volume":"102","author":"McAuley","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.riam.2013.09.014","article-title":"Highlights in pathogenic fungal biofilms","volume":"31","author":"Sardi","year":"2014","journal-title":"Rev. Iberoam. De. Micol."},{"key":"10.1016\/j.micpath.2022.105640_bib91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105640_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14728214.2019.1685493","article-title":"Emerging drugs for the treatment of onychomycosis","volume":"24","author":"Gupta","year":"2019","journal-title":"Expet Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2012.04.024","article-title":"The human nail\u2013barrier characterisation and permeation enhancement","volume":"435","author":"Walters","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/myc.12251","article-title":"Histopathological examination of nail clippings using PAS staining (HPE-PAS): gold standard in diagnosis of Onychomycosis","volume":"58","author":"Jeelani","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2022.105640_bib95","first-page":"123","article-title":"Onychomycosis: role of histopathology. Onychomycosis","author":"Flores-Gavil\u00e1n","year":"2017","journal-title":"Published online"},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib96","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apm.12835","article-title":"Exocellular extract of Fusarium oxysporum, fungus free, is able to permeate and act selectively in skin","volume":"126","author":"Sibin Melo","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.micpath.2022.105640_bib97","doi-asserted-by":"crossref","first-page":"118246","DOI":"10.1016\/j.saa.2020.118246","article-title":"Immune response and Raman scattering assessment in rats skin after contact with Fusarium oxysporum metabolites","volume":"234","author":"Correia","year":"2020","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"11","key":"10.1016\/j.micpath.2022.105640_bib98","first-page":"21","article-title":"The FT-IR and Raman spectroscopies as tools for biofilm characterization created by cariogenic streptococci","author":"Gieroba","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jemt.20229","article-title":"Micro-Raman spectroscopy used to identify and grade human skin pilomatrixoma","volume":"68","author":"Cheng","year":"2005","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.micpath.2022.105640_bib100","first-page":"47","article-title":"Introduction to the fundamentals of Raman spectroscopy","volume":"vol. 66","author":"Dietzek","year":"2018"},{"key":"10.1016\/j.micpath.2022.105640_bib101","series-title":"Fundamentals of Dispersive Optical Spectroscopy Systems","author":"Neumann","year":"2014"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib102","first-page":"26","article-title":"Human nails permeation of an antifungal candidate hydroalcoholic extract from the plant L","author":"Mendes","year":"2021","journal-title":"Rich in Saponins. Molecules"},{"key":"10.1016\/j.micpath.2022.105640_bib103","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/fmb-2017-0052","article-title":"Antibiofilm activity of propolis extract on Fusarium species from onychomycosis","volume":"12","author":"Galletti","year":"2017","journal-title":"Future Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2022.105640_bib104","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/myc.13142","article-title":"Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical Fusarium isolates","volume":"63","author":"de Chaves","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.micpath.2022.105640_bib105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.biopha.2017.12.069","article-title":"Potential role of propolis in wound healing: biological properties and therapeutic activities","volume":"98","author":"Oryan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2022.105640_bib106","first-page":"29","article-title":"Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis","author":"Siqueira","year":"2015","journal-title":"Braz. Oral Res."},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib107","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jcla.21889","article-title":"Antifungal activity of propolis against yeasts isolated from blood culture: in vitro evaluation","volume":"30","author":"Mutlu Sariguzel","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/acm.2009.0281","article-title":"Antifungal activity of propolis extract against yeasts isolated from vaginal exudates","volume":"16","author":"Dalben-Dota","year":"2010","journal-title":"J. Alternative Compl. Med."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijgo.2011.02.019","article-title":"Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis","volume":"114","author":"Shokri","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.micpath.2022.105640_bib110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.micpath.2017.02.022","article-title":"Chemical and cytotoxic analyses of brown Brazilian propolis (Apis mellifera) and its in vitro activity against itraconazole-resistant Sporothrix brasiliensis","volume":"105","author":"Waller","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2022.105640_bib111","doi-asserted-by":"crossref","first-page":"112791","DOI":"10.1016\/j.jep.2020.112791","article-title":"Propolis extract has bioactivity on the wall and cell membrane of Candida albicans","volume":"256","author":"Corr\u00eaa","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2022.105640_bib112","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/287693","article-title":"Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans","author":"Capoci","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.micpath.2022.105640_bib113","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2217\/fmb-2015-0016","article-title":"Propolis: a potential natural product to fight Candida species infections","volume":"11","author":"Tobaldini-Valerio","year":"2016","journal-title":"Future Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105640_bib114","first-page":"7","article-title":"Antifungal activity and synergism with azoles of polish propolis","author":"Gucwa","year":"2018","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/acm.2011.0696","article-title":"Brazilian green propolis extracts improve Tinea pedis interdigitalis and Tinea corporis","volume":"18","author":"Ngatu","year":"2012","journal-title":"J. Alternative Compl. Med."},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib116","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1472-765X.2008.02494.x","article-title":"Trichophyton species susceptibility to green and red propolis from Brazil","volume":"48","author":"Siqueira","year":"2009","journal-title":"Lett. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105640_bib117","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1439-0507.2005.01128.x","article-title":"Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay","volume":"48","author":"Koc","year":"2005","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.micpath.2022.105640_bib118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/S0074-02762006000500002","article-title":"Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions","volume":"101","author":"Oliveira","year":"2006","journal-title":"Mem\u00f3rias do Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.micpath.2022.105640_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/acm.2011.0722","article-title":"Yeasts as important agents of onychomycosis: in vitro activity of propolis against yeasts isolated from patients with nail infection","volume":"19","author":"Khosravi","year":"2013","journal-title":"J. Alternative Compl. Med."},{"issue":"7","key":"10.1016\/j.micpath.2022.105640_bib120","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.sjbs.2018.08.013","article-title":"Composition and functional properties of propolis (bee glue): a review","volume":"26","author":"Anjum","year":"2019","journal-title":"Saudi J. Biol. Sci."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:42:30Z","timestamp":1760110950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":120,"alternative-id":["S0882401022002534"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105640","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevant insights into onychomycosis\u2019 pathogenesis related to the effectiveness topical treatment","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105640"}}